Korro Bio, Inc. KRRO
9.57
0.00
0.00%
as of 25 Sep
- Market cap
- $140.9M
- P/E
- 0.0×
Follow KRRO
Insider Buys
alert about insiders buying in the last 12 month
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | |
|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | — | — | 0.00 | 0.00 | 0.00 | — | — |
P/S ratio |
11.77 | 9.63 | — | — | 5.00 | 30.75 | 0.00 | — | — |
P/FCF ratio |
0.00 | 0.00 | — | — | 0.00 | 0.00 | 4.57 | — | — |
P/Operating CF |
(4.25) | (45.31) | — | — | (9.85) | (76.67) | (5.10) | — | — |
P/B ratio |
1.46 | 2.12 | — | — | 1.35 | 5.91 | 0.91 | — | — |
Price to Tangible BV |
1.46 | 2.12 | — | — | 1.35 | 5.91 | 0.91 | — | — |
EV/Sales |
4.37 | 6.84 | — | — | 1.72 | 25.21 | 0.00 | — | — |
EV/EBITDA |
0.00 | 0.00 | — | — | 0.00 | 0.00 | 3.31 | — | — |
EV/Operating CF |
(0.36) | (4.02) | — | — | (0.80) | (20.63) | (1.92) | — | — |
EV/FCF |
(0.35) | (3.09) | — | — | (0.77) | (17.98) | (1.98) | — | — |
Quick Ratio |
6.38 | 8.54 | 8.53 | 6.40 | 11.45 | 8.29 | 4.13 | 11.22 | 8.06 |
Current Ratio |
6.90 | 8.79 | 8.87 | 6.56 | 11.79 | 8.45 | 4.19 | 11.38 | 8.07 |
Net Debt/EBITDA |
0.64 | 1.40 | 2.05 | 0.73 | 1.42 | 7.76 | 10.94 | (2.34) | (1.82) |
Debt/Assets |
0.00% | 0.00% | 0.00% | 19.21% | 8.09% | 5.82% | 0.00% | 190.66% | 0.00% |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.22 | 0.11 | 0.08 | 0.00 | 2.10 | 0.00 |
Asset Turnover |
0.04 | 0.01 | 0.00 | 0.00 | 0.06 | 0.15 | 0.22 | 0.00 | 0.00 |
Operating CF/Net income |
0.67 | 0.72 | 0.83 | 0.92 | 0.90 | 1.70 | (1.73) | 0.89 | 0.72 |
Capex/Depreciation |
(0.14) | (10.04) | (2.21) | (2.17) | (1.05) | (5.82) | (1.31) | (0.67) | (3.51) |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| (110.70%) | (50.61%) | (229.04%) | (365.06%) | (52.39%) | (14.73%) | (32.23%) | 51.70% | 54.58% | |
| (69.03%) | (37.32%) | (54.96%) | (44.80%) | (37.63%) | (10.87%) | (14.79%) | (86.06%) | (90.85%) | |
ROIC |
0.00% | (167.38%) | (1,404.78%) | (155.25%) | (347.42%) | 0.00% | 0.00% | (14.24%) | (35.44%) |
Return on Tangible Assets |
(149.19%) | (57.93%) | (48.06%) | (99.63%) | (65.73%) | (12.89%) | (11.62%) | (47.12%) | (115.91%) |
Average Days of Receivables |
55.33 | 272.58 | — | 0.00 | 3.74 | 3.36 | 10.15 | 0.00 | — |
Research and Development Expense of Revenue |
1,025.89% | 2,802.11% | 0.00% | 0.00% | 433.06% | 101.17% | 64.89% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
440.54% | 1,345.00% | 0.00% | 0.00% | 264.26% | 73.33% | 51.26% | 0.00% | 0.00% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
119.76% | 196.48% | 0.00% | 0.00% | 154.61% | 26.99% | 12.47% | 0.00% | 0.00% |
Graham Net Nets |
0.27 | 0.19 | — | — | 0.46 | 0.13 | 1.09 | — | — |
Graham Number |
0.00 | 0.00 | — | — | 0.00 | 0.00 | 0.00 | — | — |
Earnings Yield |
(155.68%) | (24.67%) | — | — | (48.15%) | (2.30%) | (43.18%) | — | — |
Free Cash Flow Yield |
(105.08%) | (22.96%) | — | — | (44.82%) | (4.56%) | 21.86% | — | — |
Revenue per Share |
0.68 | 0.25 | 0.00 | 0.00 | 20.48 | 57.33 | 167.32 | 0.00 | 0.00 |
Operating CF per Share |
(8.36) | (6.73) | (44.00) | (210.37) | (110.71) | (70.05) | 197.78 | (556.34) | (1,036.45) |
Capex per Share |
(0.06) | (2.01) | (5.12) | (20.14) | (4.24) | (10.34) | (6.15) | (14.25) | (132.13) |
Free Cash Flow per Share |
(8.42) | (8.74) | (49.13) | (230.51) | (114.95) | (80.39) | 191.63 | (570.59) | (1,168.58) |
Cash per Share |
8.00 | 14.13 | 108.67 | 216.66 | 190.26 | 341.56 | 1,256.39 | 1,378.73 | 1,272.13 |
Shareholders Equity per Share |
5.48 | 17.98 | 111.13 | 254.24 | 190.43 | 298.39 | 967.39 | 1,321.11 | 0.00 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
5.48 | 17.98 | 111.13 | 254.24 | 190.43 | 298.39 | 967.39 | 1,321.11 | 0.00 |
Free Cash Flow |
(79.08) | (77.98) | (75.12) | (58.78) | (78.97) | (51.86) | 33.15 | (17.46) | (16.48) |
Working Capital |
70.44 | 116.57 | 153.25 | 48.38 | 123.32 | 198.43 | 168.58 | 39.16 | 15.73 |
Capital Expenditures |
(0.52) | (17.90) | (7.84) | (5.14) | (2.91) | (6.67) | (1.06) | (0.44) | (1.86) |
Net Current Asset Value |
20.31 | 65.71 | 120.98 | 48.17 | 80.21 | 152.83 | 165.50 | 38.82 | 17.96 |
EV/EBIT |
0.00 | 0.00 | — | — | 0.00 | 0.00 | 3.18 | — | — |
Capex to Sales |
0.08 | 7.88 | 0.00 | 0.00 | 0.21 | 0.18 | 0.04 | 0.00 | 0.00 |
Net Profit Margin |
(1,834.48%) | (3,680.36%) | 0.00% | 0.00% | (601.98%) | (71.68%) | (68.40%) | 0.00% | 0.00% |
Price to Operating Income |
0.00 | 0.00 | — | — | 0.00 | 0.00 | 0.00 | — | — |
| Other line items | |||||||||
Depreciation/Fixed assets |
0.46 | 0.06 | 0.23 | 0.24 | 0.50 | 0.16 | 0.46 | 0.43 | 0.31 |
Cash ROIC |
(68.51%) | (30.64%) | (24.68%) | (47.31%) | (29.50%) | (12.25%) | 8.44% | (11.06%) | (25.29%) |
Accounts Receivable Turnover |
4.80 | 2.12 | — | 0.00 | 58.13 | 64.60 | 59.93 | 0.00 | — |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Inventory Turnover |
— | — | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Days of Inventory on Hand |
— | — | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Receivables |
1.33 | 1.07 | — | 0.30 | 0.24 | 0.57 | 0.48 | 0.48 | — |
Average Payables |
2.82 | 5.64 | 4.94 | 2.68 | 4.13 | 3.36 | 1.54 | 1.43 | 1.43 |
Average Assets |
169.87 | 223.95 | 147.70 | 129.55 | 225.04 | 243.97 | 133.88 | 22.27 | 22.27 |
Average Common Equity |
105.93 | 165.16 | 35.44 | 15.90 | 161.66 | 179.92 | 61.42 | (37.08) | (37.08) |
Columns are period end dates